Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03568071
What this trial is testing

Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lakefront Biotherapeutics NV 207
Testing effectiveness (Phase 2)Study completedNCT07752810
What this trial is testing

Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout

Who this might be right for
Gout
Hangzhou Grand Biologic Pharmaceutical, Inc. 90
Not applicableLooking for participantsNCT07127185
What this trial is testing

Individualized Precision Therapy With Ceftobiprole Guided by PK/PD in Geriatric Populations

Who this might be right for
Ceftobiprole
Chinese PLA General Hospital 150
Early research (Phase 1)Study completedNCT00481117
What this trial is testing

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 37
Early research (Phase 1)Study completedNCT03942458
What this trial is testing

Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19

Who this might be right for
Healthy SubjectsPK/PD
Jiangsu vcare pharmaceutical technology co., LTD 50
Early research (Phase 1)Study completedNCT01924091
What this trial is testing

PK/PD of Single Dose Dapivirine Vaginal Film

Who this might be right for
Pharmaokinetics
International Partnership for Microbicides, Inc. 60
Early research (Phase 1)Study completedNCT02070939
What this trial is testing

Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects

Who this might be right for
Healthy
Pfizer 72
Testing effectiveness (Phase 2)Ended earlyNCT03488251
What this trial is testing

PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin Lymphoma,B CellRefractory Diffuse Large B-Cell LymphomaRelapsed Diffuse Large B-Cell Lymphoma
Molecular Templates, Inc. 8
Not applicableUnknownNCT02959541
What this trial is testing

PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer

Who this might be right for
Colon CancerChemotherapy
Vastra Gotaland Region 48
Early research (Phase 1)Study completedNCT05896969
What this trial is testing

Dose Escalation of SNK-396 in Participants With Elevated Low-Density Lipoprotein Cholesterol

Who this might be right for
Elevated Low-Density Lipoprotein Cholesterol
Syneos Health 41
Early research (Phase 1)Study completedNCT05827653
What this trial is testing

MAD Study of NX210c

Who this might be right for
Healthy Elderly
Axoltis Pharma 29
Testing effectiveness (Phase 2)Study completedNCT01194037
What this trial is testing

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

Who this might be right for
Chronic Hepatitis C InfectionGenotype 1
HanAll BioPharma Co., Ltd. 30
Early research (Phase 1)Study completedNCT03815396
What this trial is testing

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin DeficiencyAATD
Inhibrx Biosciences, Inc 31
Testing effectiveness (Phase 2)Study completedNCT02956746
What this trial is testing

A Comparison of the Safety, PD and PK of a Single Dose of SYN023 Administered With Licensed Rabies Vaccines

Who this might be right for
Human Rabies
Synermore Biologics Co., Ltd. 164
Testing effectiveness (Phase 2)Study completedNCT04364269
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia

Who this might be right for
Beta-ThalassemiaNon-transfusion-dependent Thalassemia
Vifor (International) Inc. 35
Early research (Phase 1)Study completedNCT05745727
What this trial is testing

Evaluate the Safety, Tolerability, PK, and PD Properties of PRX-115 in Adult Volunteers With Elevated Uric Acid Levels

Who this might be right for
Gout
Protalix 64
Early research (Phase 1)Study completedNCT01110590
What this trial is testing

Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552

Who this might be right for
Erectile Dysfunction
Bayer 37
Early research (Phase 1)Study completedNCT06206824
What this trial is testing

Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease

Who this might be right for
Healthy VolunteersDown SyndromeAlzheimer's Disease
Perha Pharmaceuticals 152
Early research (Phase 1)Not Yet RecruitingNCT07688980
What this trial is testing

Study to Characterise Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Anifrolumab Administered Subcutaneously (SC) or Intravenously (IV)

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 92
Early research (Phase 1)Study completedNCT05095168
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects

Who this might be right for
PNH
CARE Pharma Shanghai Ltd. 31
Next Page